Wondering if NovoCure at around $13 is a beaten down bargain or just a value trap? Here is a look at what the numbers are quietly saying about where the stock stands today. Despite a brutal longer ...
Discover Bloomberg's 2026 Dividend Focus picks—top stocks with high yields & cash flow. See potential gainers & learn contrarian strategies.
16h
Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
Subsidiary, Citius Oncology, launches cancer immunotherapy, LYMPHIR, in the U.S. in December 2025 CRANFORD, N.J., Dec. 23, 2025 /PRNewswire/ -- Citius Pharmaceuticals ...
Cal-Maine Foods offers exposure to structurally higher egg prices driven by regulation, consolidation, and resilient demand.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback